Breaking News, Financial News

Financial Report: Charles River Laboratories

Foreign exchange impacts sales

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Laboratories   2Q Revenues: $284.7 million (-1%) 2Q Earnings: $30.6 million (-6%) YTD Revenues: $570.7 million (flat) YTD Earnings: $57.1 million (-11%) Comments: Research Models and Services sales were $173.6 million in quarter (-3%). Foreign exchange impacted sales by 3.8%. Preclinical Services sales were $111.1 million (+1%). Foreign currency exchange reduced sales by 2.1%.  ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters